Le Lézard
Classified in: Science and technology
Subject: PARTNERSHIPS

uBUCK Signs Agreement for Strategic Commercial Relationship with Deltec Bank & Trust Limited


VANCOUVER, British Columbia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- LiteLink Technologies Inc. ("LiteLink") (CSE:LLT)(OTC:LLNKF)(FRA:C0B), a key player in logistics platforms and payment solutions, is pleased to announce that its subsidiary uBUCK Technologies SEZC ("uBUCK" or the "Company") has signed a Strategic Alliance Agreement with Deltec Bank & Trust Limited ("Deltec") to sell uBUCK prepaid debit cards from the uBUCK platform to banks and investment account customers at Deltec. Through this strategic commercial relationship, Deltec will also integrate and market the uBUCK prepaid debit card into Deltec digital wallet and exchange relationships, as well as private banking contacts.

Headquartered in The Bahamas, Deltec is a diversified independent financial institution that offers its global clients the unique combination of institutional expertise, bespoke solutions, and highly attentive service.

"We are very excited to enter into a strategic partnership with Deltec, a highly regarded financial institution with a range of private banking and fiduciary expertise," said uBUCK CEO James Youn. "This partnership opens up uBUCK to a large network of financial services providers across the globe."

The phases of the strategic commercial relationship between uBUCK and Deltec will include providing prepaid debit cards to their existing bank and wealth management clients, marketing the card program to regional private bank networks in the Caribbean, South America, Asia and Europe, a technology platform that links the cards and creating dedicated white label card programs to their existing digital asset exchange clients.

About Deltec Bank & Trust Limited
Deltec Bank & Trust Limited is the flagship company of the Deltec International Group, a diversified independent financial services group, providing through its member companies a range of private banking and fiduciary expertise, fund administration, investment management, digital asset financial services, insurance solutions, and corporate and merchant banking capabilities.

About uBUCK Technologies SEZC
Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digital payments and wallets. uBUCK Pay, its online payments platform and pin voucher solution, offers consumers, businesses and merchants a fast, commission-free and highly secure alternative to traditional payments. Customers can purchase pin vouchers within the uBUCK Pay app or at participating resellers. For details about uBUCK Pay, please visit uBUCKpay.com. For details about Streambucks, please visit Streambucks.gg.

About LiteLink Technologies Inc.
LiteLink Technologies Inc. (CSE:LLT) (OTC:LLNKF) (FRA:C0B) is a major player in developing world-class enterprise platforms that utilize artificial intelligence, blockchain, and predictive analytics to solve fragmented and outdated technology problems in the logistics and digital payment industries. Our flagship 1SHIFT logistics platform offers real-time transparency and tracking which allows brokers, shippers, and carriers to track shipments and settle payments in real-time.

For further information, contact Yana Bobrovskaya at 604-307-2553 or email [email protected].

Forward-looking Statement
This news release may contain certain "Forward-Looking Statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When used in this news release, the words "anticipate", "believe", "estimate", "expect", "target", "plan", "forecast", "may", "schedule" and other similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to the nature of the business of LiteLink, and other factors or information. Such statements represent LiteLink's current views with respect to future events and are necessarily based upon a number of assumptions and estimate that, while considered reasonable by LiteLink, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. LiteLink does not intend and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affections such statements and information other than as required by applicable laws, rules and regulations.


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: